Compare DexCom, Inc. (DXCM) vs State Street Real Estate Select Sector SPDR ETF (XLRE) Price & Performance

DXCM trades at $77.31, up 4.3% on the day, with a bullish technical outlook as it approaches resistance near $78. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $0.56 surpassing expectations of $0.47. Revenue growth accelerated to $4.66 billion in 2025, while net income margin expanded to 17.93%. Recent regulatory approvals, including Health Canada authorization for the G7 15-day CGM, support continued international expansion.

The stock offers growth potential with analyst consensus price target of $84.33, though high valuation multiples (P/E 31.21) and competition in the CGM market present risks. Expansion into non-insulin Type 2 diabetes and pediatric markets could drive future revenue, but commercial uptake remains unproven. Institutional sentiment remains strongly bullish with 80% buy ratings.

XLRE, the Real Estate Select Sector SPDR ETF, trades at $44.93, up 1.01% on the day, with technical indicators signaling a bullish trend. The ETF has gained approximately 11% year-to-date, defying broader market pressures, as real estate fundamentals show resilience. Recent news highlights its low 0.08% expense ratio and steady 3.4% distribution yield, while technical analysis shows strong buy signals from moving averages and a neutral stance from oscillators.

The outlook for XLRE appears cautiously optimistic, supported by improving REIT fundamentals and a potential turning point in the sector's repricing cycle. Investment opportunities include exposure to a recovering real estate sector with low-cost efficiency, but risks persist from interest rate volatility, inflation pressures, and potential sector-wide pullbacks if bond yields rise further.